Severe nausea leading to discontinuation of treatment occurred in a minority of participants
About 12 percent of Americans have tried a GLP-1, RAND reports
The short answer is no: combining these drugs is medically unsafe and can trigger severe side effects including uncontrolled blood sugar drops, extreme nausea, and heart rhythm problems
E.KellyG
Clinical trials demonstrate that tirzepatide significantly reduces A1C levels through its dual action on GIP and GLP-1 receptors, improving insulin secretion, slowing gastric emptying, and reducing glucagon release
We will further look into this and explore how we can help patients with addiction, potentially with GLP-1, Lange said, also adding that it has to be addressed in a scientific, and obviously also from a regulatory perspective, very rigorous way so we can really see the potential impact of GLP-1 in that space. However, in response to questions from Biospace, a Novo spokesperson said that Lange was referring to the already ongoing work studying semaglutide on liver damage and alcohol use in its phase 2 trial, and that the company has no plans to study the drug in broader addiction indications